Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Research Group Viral Hepatitis and Liver Cancer

1. Increasing pandemic preparedness by computational high-throughput virus discovery: Identification of RNA viruses and host reservoirs with high spillover risk

We have a long-standing interest in the discovery and evolution of viruses in general. Our "Data-Driven Virus Discovery" (DDVD; Lauber & Seitz, 2022) strategy involves two computational pipelines, termed Virushunter and Virusgatherer, dedicated to the identification of Next-Generation sequencing (NGS) experiments positive for viral sequence reads and the

more

Figure 1. Computational virus discovery workflow. Left column: Analysis of hundreds of thousands of unprocessed NGS data sets from the Sequence Read Archive (SRA) requires enormous capacities for data storage and management. Middle column: In a first step, we apply Virushunter to detect data sets (highlighted in red) containing viral sequence fragments with high sensitivity and specificity. Right column: Only the virus-positive data sets are submitted to targeted assembly of viral genomes by Virusgatherer.
© dkfz.de

In this project embedded in the Helmholtz initiative “Corona Virus Pathogenesis” (COVIPA) we have screened >500,000 individual transcriptome sequencing datasets covering the whole spectrum of eukaryotic organisms for the presence of sequences of viral origin.  We took advantage of the fact that the genomes and transcripts of known and unknown viruses are sequenced incidentally as “bycatch”, if the source material stems from an organ, tissue or cell infected by a virus at the time of sampling. In total, we recovered ~150,000 contigs representing genomic sequences of bona fide eukaryotic RNA viruses. About two thirds of them are only distantly related to any known RNA viruses constituting whole new virus families (Fig. 2).

more

Figure 2. Phylogeny of 929 viral sequences discovered in the SRA that cluster with reference viruses from the Branch 3 RNA virus supergroup. This Maximum Likelihood tree is based on conserved regions of RdRp protein sequences. The diameters of circles placed at internal nodes are proportional to bootstrap support of the respective branching events. The colored right-justified horizontal lines extending from the tips of the tree indicate the organism group of the sequencing experiment a virus was discovered in.
© dkfz.de

We will now use these data in order to contribute both to sustainable strategies towards preparedness for future emerging infective diseases and pandemics and to better understand and control the current pandemic caused by SARS-CoV-2. We will derive, validate and apply a spillover and pandemic risk score to identify RNA viruses with highest zoonosis probability. We expect that this work will provide the basis for creating platforms for the high-throughput development of diagnostics, vaccines and antivirals for high-risk candidate virus groups.

Collaboration partners:

  • Chris Lauber, Institute for Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover.
  • Pascal Mutz, NIH, Bethesda MD, USA

References:

  • Lauber C., and  Seitz S. (2022). Opportunities and Challenges of Data-Driven Virus Discovery. Biomolecules 12, 1073. PMID: 36008967
    • Lauber C., Vaas J., Klingler F., Mutz P, Gorbalenya A.E., Bartenschlager R., and Seitz S. (2021). Deep mining of the Sequence Read Archive reveals bipartite coronavirus genomes and inter-family Spike glycoprotein recombination. bioRxive (in revision). doi: https://doi.org/10.1101/2021.10.20.465146
    • Lauber C., Seifert M., Bartenschlager R., and Seitz S. (2019). Discovery of highly divergent lineages of plant-associated astro-like viruses sheds light on the emergence of potyviruses. Virus Res. 260, 38-48. PMID: 30452944
    • Lauber C.*, Seitz S.*, **, Mattei S., Suh A., Beck J., Herstein J., Börold J., Salzburger W., Kaderali L., Briggs J.A.G., and Bartenschlager R. (2017). Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses. Cell Host Microbe. 22, 387-399.e6. PMID: 28867387

*Equal contribution, **Corresponding author

2. Tracing the origin and evolution of hepatitis B-related viruses – a model system to computationally derive viral spillover risk scores

The pilot study in which we developed and applied our above described bipartite Virushunter-Virusgatherer computational pipeline was dedicated to the discovery of viruses related to the human hepatitis B virus (HBV, family Hepadnaviridae). By screening >25,000 NGS datasets available in NCBI’s Sequence Read Archive (SRA) at that time, we were able to identify 21 novel viral species in vertebrates, 17 of them the very first hepatitis B-like viruses found in bony fish (Lauber, Seitz et al. 2017). Surprisingly, 13 of these fish viruses lacked the typical envelope protein gene and thus constituted a novel sister family of hepadnaviruses which we termed nackednaviruses. With this collection of viral genomes we were able to reliable root the hepadnaviral phylogeny. A time calibration based on endogenous hepadnaviral elements integrated into the genomes of song birds revealed that both sister families diverged from a common ancestor in the Silurian ~430 million years ago (mya). The hepadnaviral lineage had acquired its characteristic envelope protein gene ~370 mya at about the same time when the first terrestrial vertebrates (tetrapods) evolved.

more

Figure 3. Tanglegram juxtaposing the hepadna- and nackednaviral host and virus phylogenies. Left panel: ultrametric phylogenetic tree of the host species. Right panel: ultrametric phylogenetic tree of the virus species. Middle panel: virus-host associations. Abbreviations for geographic regions: Aa, Antarctica; Af, Africa; As, Asia; Eu, Europe; Na, North America; Nh, Northern Hemisphere; Nt, Neotropics. Solid lines in the virus tree indicate probable separation of viral daughter lineages due to a virus-host cospeciation event; dashed lines indicate probable virus duplication, i.e., virus speciation predating separation of the extant host lineages; and dashed lines with arrow indicate a host switch and its direction, i.e., virus speciation postdating separation of the extant host lineages. From Lauber, Seitz et al. 2017. © The Authors. Published by Elsevier Inc. User License: Creative Commons Attribution (CC BY 4.0).

Remarkably, we observed quite distinct patterns of virus-host association: While the viruses infecting tetrapods underwent a long-term co-evolution in intimate association with their respective hosts, the fish viruses frequently jump between hosts (Fig. 3). Through regular search updates, our virus taxon sampling meanwhile further grew to almost 100 novel viral genomes. In many cases we find closely related nackednaviruses infecting distantly related fish species, further corroborating their inherent tendency to repeated host-switches. Thus, the nackedna-/hepadnavirus sister groups represent an optimal model system to develop and test computational approaches for deriving viral spillover risk scores that shall subsequently be applied to the tens of thousands novel RNA viruses in order to contribute to future pandemic preparedness (see above).

Collaboration partners:

  • Chris Lauber, Institute for Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover.
  • Pascal Mutz, NIH, Bethesda MD, USA
  • Simone Mattei, EMBL Heidelberg

References:

  • Lauber C.*, Seitz S.*, **, Mattei S., Suh A., Beck J., Herstein J., Börold J., Salzburger W., Kaderali L., Briggs J.A.G., and Bartenschlager R. (2017). Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses. Cell Host Microbe. 22, 387-399.e6. PMID: 28867387

*Equal contribution, **Corresponding author

  • Beck J., Seitz S., Lauber C., and Nassal M. (2021). Conservation of the HBV RNA element epsilon in nackednaviruses reveals ancient origin of protein-primed reverse transcription. Proc. Natl. Acad. Sci. U S A. 118, e2022373118. PMID: 33753499
  • Glebe D.*, Goldmann N., Lauber C., and Seitz S.* (2021). HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals. Antiviral Res. 186, 104973. PMID: 33166575

*Co-corresponding authors

 

3. Elucidating the role of anelloviruses in human pathogenesis

Anelloviruses are a highly diverse group of non-enveloped viruses with circular single-stranded DNA genomes ranging between 2.0-3.8 kb. These viruses are ubiquitously present in humans and other vertebrates where they establish persistent infections. Currently, their potential role in development of human diseases, particularly cancer and autoimmune disorders, remains elusive.

We utilize our high-throughput computational pipeline for virus discovery in order to detect anellovirus sequences both in publicly accessible NGS data and in protected NGS data from cancer patients to which we get exclusive access through collaboration partners at the DKFZ.

Frequently, we detect several family members simultaneously within the same sequencing sample. From these observations we conclude that anelloviruses build viral communities or swarms composed of distinct viral lineages co-occurring in one and the same host and tissue (Fig. 4). Thus, it is possible that it is a dysbalance in the composition of such communities rather than the mere presence of these viruses that contributes to pathogenesis. We hypothesize that, although in many cases not causing harm over years or decades, emerging dysbalances in the structure of these complex viral swarms might drive disease onset and progression.

more

Figure 4. Swarms of anelloviruses in certain cancer patients. Bottom panel: Phylogenetic tree of Rep proteins from 56 reference anelloviruses (black branches) and 213 novel anelloviruses identified in NGS data of cancer patients (red branches). Middle panel: Bar chart depicting the detection frequency of a specific anellovirus in different patients. Color code: cancer types A – Q. Top panel: Network analysis. Each dot represents an individual cancer patient connected to the detected anelloviruses by solid lines. Dot size is proportional to the number of detected viruses. Color code: cancer types A – Q. In a subgroup of patients with cancer type A (marked with a grey circle) we repeatedly detect a distinct swarm composed of up to seven distantly related anelloviruses.
© dkfz.de

To this end, it is not sufficient just to identify novel viral sequences but their occurrence has to be thoroughly correlated to i) the disease conditions between infected individuals, ii) the course of disease (progression) within an individual and iii) between healthy and pathological tissues. Currently, we aim at a comprehensive description of the spectrum of human anelloviruses by our screening approach.  We will then perform computational and laboratory analyses to reveal i) the disease association of identified viral species and subgroups, ii) the presence of viral oncogenes and iii) epidemiological data regarding the viral prevalence and the related risk of disease.

The controlled NGS data provided by our internal collaboration partners create an ideal opportunity to tackle these questions. This project is a proof-of-concept study that can be extended to any kind of DNA and RNA viruses in order to unmask so far hidden oncoviruses.

Our collaboration partners at the DKFZ are:

  • Peter Lichter & Marc Zapatka, Molecular Genetics (B060)

Stefan Pfister & Natalie Jäger, Pediatric Neurooncology (B062)

4. Dynamics of hepatitis B virus morphogenesis and its alterations during chronic infection

Chronic hepatitis B is the major driver for the development of liver cirrhosis and primary liver cancer globally accounting for more than 800 thousand deaths per year. In the serum of patients chronically infected with the hepatitis B virus (HBV) one does not only find complete DNA-containing virions, but also virions harboring “empty” or RNA-containing capsids. The proportion of these non-canonical forms of virions in chronic carriers varies drastically depending on the intrahepatic viral replication activity and the treatment status. Currently, there is little known about the ultrastructural and biochemical foundations of particle morphogenesis giving rise to these non-canonical particles.

In earlier research work we identified two distinct morphotypes of hepatitis B virions in the blood circulation (Seitz et al., 2007). Based on this observation, we subsequently discovered a unique maturation step that slowly renders secreted virions infectious: Virions become released from the host cell in an inactive form and successively develop infectivity due to the translocation of their major receptor binding determinant across the viral membrane onto the outer particle surface (Seitz et al., 2016).

These findings led us to propose that HBV particles are subject to defined ultrastructural dynamics with a series of thermodynamically driven, temporally and spatially regulated events during particle morphogenesis (Fig. 3 and Seitz et al., 2020). This might be key to determining the fate of nucleocapsids in the host cell by deciding between either secretion as enveloped virions or recycling to the nucleus to sustain the pool of viral covalently closed circular DNA, which is the central reservoir for lifelong HBV persistence.

more

Figure 5. Proposed model of ultrastructural dynamics during and after HBV particle morphogenesis.
© dkfz.de

In order to dissect the proposed chain of events, we will characterize nucleocapsids containing the authentic replication complex by biochemical and structural biology methods. The nucleocapsids will be arrested in different maturation states and subjected to structure determination by cryo-electron microscopy. We will investigate the impact of any structural changes on the binding competence of nucleocapsids to surface protein segments as prerequisite for capsid envelopment. Moreover, we perform thorough biochemical interaction studies to quantitatively describe the binding kinetics of nucleocapsids to the HBV surface glycoproteins. Nuclear magnetic resonance techniques will be applied to resolve the structure of surface protein segments bound to nucleocapsids (Harati Taji et al., 2022). The insight gained into structural details and the biochemical parameters of the interactions determining nucleocapsid envelopment will allow us the quantitative characterization and modelling of the pathways of HBV particle morphogenesis with respect to their variability during chronic infection.

Collaboration partners:

  • Anne Schütz, Department of Chemistry, LMU Munich
  • Simone Mattei, EMBL Heidelberg
  • Walter Mier, Nuclear Medicine, University Clinics, Heidelberg
  • Ursula Klingmüller, DKFZ, Systems Biology of Signal Transduction (B200)

References:

  • Harati Taji Z., Bielytskyi P., Shein M., Sani M.A., Seitz S.*, and Schütz A.K.* (2022). Transient RNA Interactions Leave a Covalent Imprint on a Viral Capsid Protein. J. Am. Chem. Soc. 144, 8536-8550. PMID: 35512333

*Co-corresponding authors

  • Seitz S., Habjanič J., Schütz A.K., and Bartenschlager R. (2020). The Hepatitis B Virus Envelope Proteins: Molecular Gymnastics Throughout the Viral Life Cycle. Annu. Rev. Virol. 7, 263-288. PMID: 32600157
  • Seitz S., Iancu C., Volz T., Mier W., Dandri M., Urban S., and Bartenschlager R. (2016). A Slow Maturation Process Renders Hepatitis B Virus Infectious. Cell Host Microbe. 20, 25-35. PMID: 27321908
  • Seitz S., Urban S., Antoni C., and Böttcher B. (2007). Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J. 26, 4160-7. PMID: 17762862

to top
powered by webEdition CMS